TARS - Tarsus Pharmaceuticals GAAP EPS of -$2.52 revenue of $25.82M March, 13 2023 04:56 PM Tarsus Pharmaceuticals Inc. 2023-03-13 16:56:55 ET Tarsus Pharmaceuticals press release ( NASDAQ: TARS ): FY GAAP EPS of -$2.52. Revenue of $25.82M (-54.7% Y/Y). For further details see: Tarsus Pharmaceuticals GAAP EPS of -$2.52, revenue of $25.82M